Qiang Liu

机构：Guangzhou University of Chinese Medicine, Leiden University, Nanjing University of Chinese Medicine, Guiyang Medical University, Chinese Academy of Sciences, Ningxia University, Affiliated Hospital of Guizhou Medical University, Shanghai Institute of Materia Medica, Drug Discovery Laboratory (Norway), Carbohydrate Competence Center, University of Chinese Academy of Sciences, Southern Medical University · ORCID：0000-0003-1229-7908

发表论文 59 篇 · 总被引 1054 次 · h-index 17

代表论文

• Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal (2021 · Nature Communications · 被引 62)
• Reading ADP-ribosylation signaling using chemical biology and interaction proteomics (2021 · Molecular Cell · 被引 53)
• Molecular Tools for the Study of ADP‐Ribosylation: A Unified and Versatile Method to Synthesise Native Mono‐ADP‐Ribosylated Peptides (2021 · Chemistry - A European Journal · 被引 36)
• Time-resolved FRET and NMR analyses reveal selective binding of peptides containing the LC3-interacting region to ATG8 family proteins (2019 · Journal of Biological Chemistry · 被引 21)
• Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimics (2021 · Bioorganic Chemistry · 被引 17)
• Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models (2020 · Journal of Pharmaceutical Sciences · 被引 15)